Programmable RNA base editing via targeted modifications.

Area of Science:

• Biotechnology
• Molecular Biology
• Genetic Engineering

Background:

• CRISPR genome editors offer powerful therapeutic potential but carry risks of permanent off-target mutations.
• DNA base editors (e.g., cytosine, adenine) correct genetic errors but permanent off-target edits pose significant risks.
• RNA base editing provides a temporary, reversible approach to correct mutations without lasting genotoxic effects.

Purpose of the Study:

• To summarize emerging RNA base editors and their mechanisms.
• To review programmable RNA-targeting systems and effector proteins.
• To discuss technological advancements, limitations, and future directions in RNA base editing.

Main Methods:

• Review of current literature on RNA base editing technologies.
• Analysis of RNA editing systems based on A-to-inosine, C-to-U, and U-to-pseudouridine changes.
• Examination of programmable RNA-targeting systems and modification enzyme-based effectors.

Main Results:

• Emerging RNA editors based on specific base conversions (A-to-I, C-to-U, U-to-Ψ) are being developed.
• Programmable RNA-targeting systems and effector proteins are key components of these editors.
• Recent technological breakthroughs have advanced the capabilities of RNA base editing.

Conclusions:

• RNA base editing presents a promising therapeutic strategy due to its temporary and reversible nature.
• Further research is needed to overcome limitations and fully realize the potential of RNA base editing tools.
• Future directions include refining editing efficiency, specificity, and delivery for clinical applications.